Notably, in small cell lung cancer (SCLC), this effect was reversed when chemotherapy was combined with CDK4/6 inhibitors, which suppressed chemoresistance by inducing cell death through the lysosomal dysfunction and autophagy [76]. This evidence concerns the gene CDK4 and small cell lung carcinoma.